Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular intrahepatic portosystemic shunt (TIPS) has not been established. ⋯ French Public Health Ministry.
-
Randomized Controlled Trial Multicenter Study
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Zika virus (ZIKV) may cause severe congenital disease after maternal-fetal transmission. No vaccine is currently available. ⋯ Janssen Vaccines and Infectious Diseases.
-
Most psychiatric care is delivered in primary care settings, where depression is the most common presenting psychiatric symptom. Given the high prevalence of depression worldwide and the well-established consequences of untreated depression, the ability of primary care clinicians to effectively diagnose and treat it is critically important. This article offers up-to-date guidance for the diagnosis and treatment of major depressive disorder, including practical considerations for delivering optimal and efficient care for these patients.
-
Multicenter Study
Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States.
The coronavirus disease 2019 (COVID-19) pandemic continues to surge in the United States and globally. ⋯ Agency for Healthcare Research and Quality.
-
Identifying occupational risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among health care workers (HCWs) can improve HCW and patient safety. ⋯ Emory COVID-19 Response Collaborative.